{
  "retracted": false,
  "timestamp": 1543622400000,
  "updates": [
    {
      "timestamp": 1585055210574,
      "identifier": {
        "doi": "10.1016/j.lungcan.2018.11.007"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.lungcan.2017.11.019"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab” [Lung Cancer 115 (2018) 71–74]"
}
